Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€2.83
20.10.21
€5.00
31.12.23
-62.30%
08.05.23

Could be very worthwhile Investment >20% year
buy
Applied Genetic Technologies Corp.

Start price
Target price
Perf. (%)
€2.28
20.10.21
€5.00
31.12.23
-84.94%
08.05.23

Could be very worthwhile Investment >20% year
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€29.94
20.10.21
€35.00
31.12.23
65.15%
05.08.22

Could be very worthwhile Investment >20% year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€110.32
20.10.21
-
20.10.22
18.64%
31.10.21

buy
Omeros Corp.

Start price
Target price
Perf. (%)
€5.21
19.10.21
-
19.10.22
19.09%
05.11.21

Could be worthwhile Investment >10% per year
buy
Adamis Pharmaceuticals Corp.

Start price
Target price
Perf. (%)
€86.17
18.10.21
-
18.10.22
-27.62%
30.10.21

buy
Fennec Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.45
18.10.21
€12.00
31.12.23
-2.68%
08.05.23

Could be very worthwhile Investment >20% year
buy
Adverum Biotechnologies Inc.

Start price
Target price
Perf. (%)
€1.75
18.10.21
-
18.10.22
13.14%
30.10.21

buy
Adverum Biotechnologies Inc.

Start price
Target price
Perf. (%)
€1.75
18.10.21
-
18.10.22
13.14%
30.10.21

buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€2.32
18.10.21
-
18.10.22
6.90%
30.10.21

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€24.07
18.10.21
€36.00
18.10.22
31.49%
17.11.21

Revenue growth >5% per year expected
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Risky balance sheet
buy
Adamis Pharmaceuticals Corp.

Start price
Target price
Perf. (%)
€69.30
18.10.21
€70.00
18.10.22
-85.22%
19.10.22

Valneva SE

Start price
Target price
Perf. (%)
€15.87
18.10.21
-
18.10.22
7.88%
10.01.22

buy
Valneva SE

Start price
Target price
Perf. (%)
€15.83
18.10.21
-
18.10.22
23.75%
31.10.21

Could be very worthwhile Investment >20% year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€5.30
18.10.21
-
18.10.22
-15.62%
30.10.21

Risky Investment
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€16.50
18.10.21
€30.00
18.10.22
-76.27%
19.10.22

buy
Merck KGaA

Start price
Target price
Perf. (%)
€192.35
18.10.21
-
18.10.22
2.99%
20.10.21

Omeros Corp.

Start price
Target price
Perf. (%)
€6.84
18.10.21
-
18.10.22
-29.51%
18.10.21

buy
Kineta Inc.

Start price
Target price
Perf. (%)
€53.20
18.10.21
€84.00
31.12.23
-96.49%
08.05.23

Could be very worthwhile Investment >20% year
Biogen Inc.

Start price
Target price
Perf. (%)
€243.10
18.10.21
€210.00
02.01.23
-12.53%
16.12.21

Could be worthwhile Investment >10% per year
buy
Cti Biopharma Corp

Start price
Target price
Perf. (%)
€2.47
17.10.21
€4.00
31.12.23
112.17%
28.06.22

Could be very worthwhile Investment >20% year
buy
Coherus Bioscien.

Start price
Target price
Perf. (%)
€14.60
17.10.21
€20.00
31.12.23
-54.93%
08.05.23

Could be very worthwhile Investment >20% year
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€29.43
17.10.21
-
17.10.22
72.85%
15.09.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Capable Management
Innovative
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€2.48
17.10.21
-
17.10.22
0.00%
30.10.21

buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€16.83
17.10.21
-
17.10.22
-1.25%
30.10.21

Could be very worthwhile Investment >20% year